HeartCore signs fifth Go IPO consulting deal with SBC Medical; $900k fees plus 2.7% warrant

HeartCore Enterprises, Inc.

HeartCore will receive $900,000 in initial fees under consulting agreement with SBC Medical.
HeartCore also received a warrant for 2.7% of SBC Medical's fully diluted common stock, exercisable at $0.01 per share after IPO.
Fifth Go IPO agreement in eight months; company assists Japanese firms with Nasdaq listing.
Previously, HeartCore and SYLA amended their consulting deal, terminating a warrant in exchange for contingent cash payment.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

HeartCore Enterprises, Inc. entered into SBC Consulting Agreement with SBC Medical Group, Inc. (SBC Medical) valued at $900,000 (effective 2022-11-18).

Action: entry
Counterparty: SBC Medical Group, Inc. (SBC Medical)
Value: $900,000
Effective: 2022-11-18

Exact text from the filing

On November 18, 2022 (the “Effective Date”), the Company entered into a Consulting and Services Agreement (the “SBC Consulting Agreement”) by and between the Company and SBC Medical Group, Inc., a Japanese corporation (“SBC Medical”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

HeartCore Enterprises, Inc. entered into Rights Allotment Agreement with SYLA Technologies Co., Ltd. (SYLA) (effective 2022-11-09).

Action: entry
Counterparty: SYLA Technologies Co., Ltd. (SYLA)
Effective: 2022-11-09

Exact text from the filing

On November 9, 2022, HeartCore Enterprises, Inc. (the “Company”) entered into the 9 th Stock Acquisition Rights Allotment Agreement (the “Rights Allotment Agreement”) by and between the Company and SYLA Technologies Co., Ltd. (“SYLA”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

HeartCore Enterprises, Inc. amended Amendment No. 2 to the Consulting Agreement with SYLA Technologies Co., Ltd. (SYLA) (effective 2022-11-15).

Action: amendment
Counterparty: SYLA Technologies Co., Ltd. (SYLA)
Effective: 2022-11-15

Exact text from the filing

On November 15, 2022, the Company and SYLA entered into Amendment No. 2 to the Consulting Agreement (“Amendment No. 2”).

View on SEC.gov

Browse all material agreements →

HeartCore Enterprises, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-033440

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.